SAS Output

26-MAY-2017 18:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1216-Pros Adv, ADT +/- TAK-700 or Bic 1 Y 1 LHRHa + TAK-700 1304 635 129 59 32 8 0 03/08/2013 143 154
        2 LHRHa + Bicalutamide   637 128 62 30 8 2      
            1272 257 121 62 16 2      
 
  S1314-Blad, COXEN Neoadj. Chemo + Cyst 1 Y 1 GC+CYST 230 99 48 23 16 6 3 08/28/2014 232 112
        2 DDMVAC+CYST   94 44 22 15 5 0      
            193 92 45 31 11 3      
 
  S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 180 9 9 6 2 0 0 07/25/2016 191 82
        2 Cabozantinib   9 9 5 2 1 0      
        3 Crizotinib   10 10 6 3 2 0      
        4 Savolitinib   11 11 8 5 2 0      
            39 39 25 12 5 0      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 4 4 4 4 1 0 02/24/2017 74 37
        2 Tokyo-172 BCG   2 2 2 2 0 0      
        3 Prime + Tokyo-172 BCG   3 3 3 3 2 1      
            9 9 9 9 3 1      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 148 3 3 3 3 1 1 03/13/2017 93 42
            3 3 3 3 1 1      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   2 2 1 1 0 0 11/23/2016 6 5
            2 2 1 1 0 0      
 
  E2810-Renal, Pazopanib vs Placebo 1 E Total Registrations   46 8 2 1 0 0 10/31/2012 173 83
            46 8 2 1 0 0      
 
No EA8141-UTUC, HG, Chemo then Surg 1 E Total Registrations   8 5 2 2 1 0 02/23/2016 159 75
            8 5 2 2 1 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   45 27 17 8 3 0 11/25/2013   153
            45 27 17 8 3 0